I obtained my PhD at Nantes University in France. During my PhD, I worked on ribosome display selection of anti-CD38 Affitins (artificial proteins binding to antigens) for PET imaging of multiple myeloma. Thereafter, I started my first postdoc at Commissariat a l’Energie Atomique (CEA; Paris, Frankrijk). Here, my project was to use yeast display for the selection of antibodies against SARS-CoV2.
In June 2023, I joined the Princess Máxima Centrum as a postdoc for the Protein Facility. My main focus is to set up protein display approaches (yeast and phage display) combined with deep sequencing for high-throughput selection of antibodies and nanobodies with favorable properties for promising targets in pediatric oncology. The selected antibodies and nanobodies can be used in various applications, such as PET imaging, drug conjugation, or CAR-T cell therapies, to improve outcomes for children with cancer.